Medicare fee schedule, pay for performance top concerns

ASCRS and the American Academy of Ophthalmology are working together to develop measures of performance.

Related Videos

View All

Related Content

Glaucoma 360: Drug targets and reduces episcleral venous pressure in glaucoma

February 3rd 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

4D Molecular Therapeutics announces FDA clearance of IND application for 4D-150 genetic medicine for the treatment of DME

February 3rd 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

May 12th 2022

Novel gene therapy shows promise for treating multiple eye diseases

February 3rd 2023

International Keratoconus Academy continues to provide cutting-edge education

February 2nd 2023

Glaucoma 360: Drug targets and reduces episcleral venous pressure in glaucoma

February 3rd 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

4D Molecular Therapeutics announces FDA clearance of IND application for 4D-150 genetic medicine for the treatment of DME

February 3rd 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

May 12th 2022

Novel gene therapy shows promise for treating multiple eye diseases

February 3rd 2023

International Keratoconus Academy continues to provide cutting-edge education

February 2nd 2023

Glaucoma 360: Drug targets and reduces episcleral venous pressure in glaucoma

February 3rd 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

4D Molecular Therapeutics announces FDA clearance of IND application for 4D-150 genetic medicine for the treatment of DME

February 3rd 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

May 12th 2022

Novel gene therapy shows promise for treating multiple eye diseases

February 3rd 2023

International Keratoconus Academy continues to provide cutting-edge education

February 2nd 2023

Related Content

---

Glaucoma 360: Drug targets and reduces episcleral venous pressure in glaucoma

Article

---

Commercial real estate and your practice, part two with Colin Carr

Podcast

---

4D Molecular Therapeutics announces FDA clearance of IND application for 4D-150 genetic medicine for the treatment of DME

Article

---

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

Podcast

---

Novel gene therapy shows promise for treating multiple eye diseases

Article

---

International Keratoconus Academy continues to provide cutting-edge education

Article